This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Dev

Joined: October 9, 2025
Articles: 6278

survey

Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimers Disease

Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy

Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Apathy in Alzheimers Disease Methyphenidate Trial II (ADMET II)

Apathy in Alzheimers Disease Methyphenidate Trial II (ADMET II) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Cognitive training and practice effects in MCI

Cognitive training and practice effects in MCI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Benfotiamine in Alzheimers Disease: A pilot study

Benfotiamine in Alzheimers Disease: A pilot study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Aerobic Exercise in Alzheimers Disease: Cognition and Hippocampal Volume Effects

Aerobic Exercise in Alzheimers Disease: Cognition and Hippocampal Volume Effects Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Olfactory deficits and donepezil treatment in cognitively impaired elderly

Olfactory deficits and donepezil treatment in cognitively impaired elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Reducing Agitation in Dementia Patients at Home: The Customized Activity Trial

Reducing Agitation in Dementia Patients at Home: The Customized Activity Trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Dominantly Inherited Alzheimers Network Trials Unit – Adaptive Prevention Trial

Dominantly Inherited Alzheimers Network Trials Unit – Adaptive Prevention Trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016